Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.Sweta Chekuri, Bryan J. McVerry, José Carlos Nicolau et al.|Bristol Research (University of Bristol)|2021Cited by 589
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trialBrett L. Houston, Ryan Zarychanski, Patrick R. Lawler et al.|Clinical Trials|2020Cited by 68
Therapeutic Anticoagulation in Non-Critically Ill Patients with Covid-19Ryan Zarychanski, Patrick R. Lawler, Ewan C. Goligher et al.|medRxiv|2021Cited by 19